Santen Pharmaceutical CEOs: 4 Presidents Since 1990

Revenue and CEOs4 CEOs
Santen Pharmaceutical
CEOs and long-term results
FY2026
Consolidated
Revenue
¥291.6 billion
Net margin
12.8%
MoritaKurokawaTaniuchiIto
Revenue¥2.5 billionRevenue¥8.0 billionRevenue¥98.4 billionRevenue¥195.3 billionRevenue¥291.6 billionNet margin3.9%Net margin4.5%Net margin13.2%Net margin27.3%Net margin12.8%1963/31966/31971/31976/31981/31986/31991/31996/32001/32006/32011/32016/32021/32026/3
Revenue¥2.5 billionRevenue¥98.4 billionRevenue¥291.6 billionNet margin3.9%Net margin13.2%Net margin12.8%1963/31966/31976/31986/31996/32006/32016/32026/3
API: /api/4536/financials_history.csv · /api/4536/financials/pl.json
Tenure timeline
19902000201020202030
Takakazu MoritaAkira KurokawaShigeo TaniuchiTakeshi Ito
Presidents4

Presidents

NameFromToYearsBackgroundEducation
Takakazu MoritaOct 1990Company veteran
Akira KurokawaJun 2006Company veteran
Shigeo TaniuchiApr 2018Sep 20224.4Company veteranRikkyo University, Faculty of Science, Chemistry (1996)
Takeshi ItoSep 2022Present4.2Company veteran